Name: Quantum BioPharma Ltd. (QNTM) Financial Statements
Creator: FinSpry

Quantum BioPharma Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Quantum BioPharma Ltd. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	6.08	3.86	6.91	6.33	7.83
Selling, General & Administrative	9.31	9.03	14.45	23.37	10.06
Operating Expenses	15.88	19.23	27.43	33.74	30.69
Operating Income	-15.88	-19.23	-27.43	-33.74	-30.69
Other Income/Expense
Interest Income	0.57	0.79	0.37	0.00	0.00
Interest Expense	0.05	0.00	-0.05	0.07	-0.24
Other Income/Expense	0.44	0.21	0.52	-0.13	-2.57
Income
Income Before Tax	-14.92	-18.23	-26.70	-33.94	-28.36
Income Tax Expense	0.00	0.00	0.00	0.00	0.77
Net Income	-14.20	-17.90	-23.61	-35.29	-31.80
Net Income - Continuous Operations	-14.92	-18.23	-26.70	-33.94	0.00
Net Income - Discontinued Operations	0.00	0.00	3.10	-1.35	0.00
EBITDA	-14.38	-16.73	-22.90	-29.82	-24.46
EBIT	-14.87	-19.23	-27.43	-33.87	-28.36
Depreciation & Amortization	0.49	2.51	4.53	4.05	3.90
Earnings Per Share
Basic EPS	-13.00	-29.00	-40.00	-66.00	-3.00
Diluted EPS	-13.00	-29.00	-40.00	-66.00	-3.00
Basic Shares Outstanding	1.14	0.61	0.60	0.54	12.05
Diluted Shares Outstanding	1.14	0.61	0.60	0.54	12.05